UBS Group
CRKN

UBS Group’s Crown Electrokinetics Corp. Common Stock CRKN Stock Holding History

UBS Group’s Portfolio CRKN Stock Details CRKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-617
Closed -$13.1K – 11025
2024
Q4 		$13.1K Buy
617
+607
+6,070% +$66.9K ﹤0.01% 8163
2024
Q3 		$1.76K Sell
10
-8
-44% -$2.79K ﹤0.01% 8559
2024
Q2 		$12.1K Buy
18
+16
+800% +$25.1K ﹤0.01% 7610
2024
Q1 		$2.7K Buy
+2
New +$4.65K ﹤0.01% 7845
2023
Q4 		– Sell
-1
Closed -$5.27K – 8503
2023
Q3 		$6.12K Buy
+1
New +$63.4K ﹤0.01% 7317
2023
Q2 		– Hold
0
– – – 7040
2023
Q1 		– Hold
0
– -$4.07K – 10614
2022
Q4 		– Hold
0
– – – 9393
2022
Q3 		– Hold
0
– -$6K – 11088
2022
Q2 		– Hold
0
– – – 8749
2022
Q1 		– Hold
0
– -$18K – 11049
2021
Q4 		– Hold
0
– – – 7997
2021
Q3 		– Hold
0
– – – 7606
2021
Q2 		– Hold
0
– – – 7988
2021
Q1 		– Hold
0
– – – 7817

Other funds holding CRKN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's CRKN Position: Q1 2025 in Review

UBS Group sold out of Crown Electrokinetics Corp. Common Stock (CRKN) in Q1 2025, closing a stake of 617 shares — an estimated $13.1K sold.

UBS Group first reported a position in CRKN in Q3 2023 and held it in 5 quarters. The position peaked at $13.1K in Q4 2024. 1 fund tracked by Wall St. Rank holds CRKN as of Q1 2025.

  • UBS Group reported no remaining Crown Electrokinetics Corp. Common Stock position as of Q1 2025 after selling out during the quarter.
  • UBS Group sold 617 Crown Electrokinetics Corp. Common Stock shares in Q1 2025, an estimated $13.1K.
  • UBS Group first reported a position in Crown Electrokinetics Corp. Common Stock in Q3 2023 and held it in 5 quarters.
  • UBS Group's Crown Electrokinetics Corp. Common Stock position peaked at $13.1K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Crown Electrokinetics Corp. Common Stock as of Q1 2025.

Based on UBS Group's 13F filing for Q1 2025, filed 13 May 2025.